The importance of long-chain polyunsaturated fatty acids (LCPs) in the development of preterm infants is now well accepted but the source of dietary LCPs to be added to infant formulas remains controversial. We measured dietary intakes, fecal output, and percentages of intestinal absorption of nϪ6 and nϪ3 LCPs in healthy preterm infants fed exclusively preterm breast milk (PBM; n = 20), formula without LCPs added (NLCPs; n = 19), formula with LCPs derived from phospholipids (PL-LCPs; n = 19), or formula with LCPs from triacylglycerols (TG-LCPs; n = 19). Intestinal absorption of arachidonic acid was not different in the four groups but docosahexaenoic acid was better absorbed from PL-LCPs than from PBM (88.3 ± 1.8% compared with 78.4 ± 4.0%, P < 0.05) Total absorption of nϪ6 LCPs was not different between groups but total nϪ3 LCPs were better absorbed from PLLCPs than from PBM or TG-LCPs (88.7 ± 1.9%, 79.2 ± 4.4%, and 80.4 ± 2.2%, respectively). In conclusion, docosahexaenoic acid and arachidonic acid were absorbed as efficiently from TG-LCPs formula as from breast milk fat. Absorption of docosahexaenoic acid and nϪ3 LCPs was greater from PL-LCPs formula than from PBM or TG-LCPs formula.
INTRODUCTION
Arachidonic acid (AA, 20:4nϪ6) and docosahexaenoic acid (DHA, 22:6nϪ3) are the predominant long-chain polyunsaturated fatty acids (LCPs) derived by chain elongation and desaturation of the parent essential fatty acids linoleic acid (18:2nϪ6) and linolenic acid (18:3nϪ3), respectively. LCPs may be conditionally essential for premature infants (1) (2) (3) . AA was associated with growth of fetuses (4) and infants (5) . Although it was shown that both preterm (6) and full-term infants (7) are capable of synthesizing AA and DHA from linoleic acid and linolenic acid, infants who consumed formulas containing DHA had better early visual acuity than control infants (1) (2) (3) 8) . The finding of higher concentrations of LCPs in the brains of infants who died from sudden infant death and were breast-fed than in the brains of bottle-fed control infants also supports the current view of the importance of dietary LCPs during infant development (9, 10) .
Very little information is available on the amount and ideal source of LCPs to be added to formulas consumed by infants. It is still unclear whether the fat blend in infant formulas should mimic that in breast milk as much as possible or whether dietary intake of LCPs should produce plasma concentrations and biological effects similar to those in the fetus in utero or in breast-fed infants. Breast milk fat consists of 98% triacylglycerols, 1% phospholipids, and 0.5% cholesterol and cholesterol esters (11) . Although this composition remains rather constant throughout lactation, fatty acid composition of these lipid classes is affected by diet. DHA, for instance, is found in amounts ranging from 0.05% to 1.4% of total fatty acids (12) . LCPs in breast milk are mainly in triacylglycerols, in which they are primarily esterified at the sn-2 and sn-3 positions (13, 14) , but they also occur in phospholipids (15) .
In formulas for infants, LCPs are added to the fat blend by using relatively highly unsaturated lipids, such as fish oil (mainly triacylglycerols), designer oils (mainly triacylglycerols) derived from unicellular organisms, or egg phospholipids. These products differ from breast milk lipids and differences in metabolism might be expected. The differences could result from a different fatty acid composition, from different proportions of triacylglycerols and phospholipids in the fat blend, and from differences in molecular structure.
Little is known about the intestinal handling of highly unsaturated molecular species reported to be relatively resistant to the action of pancreatic lipase (16) . Hernell at al (17) found relative resistance to hydrolysis of triacylglycerols containing AA and eicosapentaenoic acid (20:5nϪ3) when triacylglycerols from rat chylomicrons were incubated in vitro with human pancreatic lipase and colipase. Few data are currently available (18) on intestinal absorption of LCPs in preterm infants, who often have impaired fat absorption during the first weeks of life (19) (20) (21) (22) . We studied dietary intakes, fecal excretion, and intestinal absorption of LCPs in preterm infants fed exclusively preterm breast milk Intestinal absorption of long-chain polyunsaturated fatty acids in preterm infants fed breast milk or formula [1] [2] [3] Virgilio P Carnielli, Giovanna Verlato, Fabio Pederzini, Ingrid Luijendijk, Anneke Boerlage, Dino Pedrotti, and Pieter JJ Sauer (PBM), preterm formula without LCPs added (NLCPs), or preterm formulas supplemented with LCPs derived from egg phospholipids (PL-LCPs) or LCPs from triacylglycerols derived from unicellular organisms (TG-LCPs).
SUBJECTS AND METHODS

Subjects and clinical design
Four groups of preterm infants were fed either PBM (n = 20), NLCPs (n = 19), PL-LCPs (n = 19), or TG-LCPs (n = 19) formula. Composition of feedings is shown in Table 1 . All infants were fed exclusively with either PBM or one of the study formulas until they were ≥5-wk old. Infants were free of major diseases and were growing at the time of the study. Clinical characteristics of the infants are shown in Table 2 . Participation in the study was voluntary and written informed consent was obtained from the infants' parents. The project was approved by the Ethics Committee of Sophia Children's Hospital/Erasmus University Rotterdam, Rotterdam, Netherlands, which agrees with the principles in the Declaration of Helsinki. Subject assignment was done randomly on the basis of unavailability of breast milk or parental decision not to breast-feed. Analyses were conducted by researchers who were blinded to the dietary assignment.
The study consisted of 72-h metabolic balance assessments and gas-chromatographic determinations of dietary and fecal fatty acids. The balance evaluations were performed in infants 28-d old. Fat and fatty acid composition of PBM was obtained from direct determinations in milk samples representative of the milk fed to each infant during the study. Values for the protein and carbohydrate contents of PBM were obtained from the study by Anderson et al (23) . Total lipids were extracted from milk by using the Röse-Gottlieb method (24) and amounts were determined gravimetrically. Plasma concentrations of fatty acids in infants fed PBM were reported recently (25) . The NLCPs and TG-LCPs formulas were produced exclusively for this study (Nutricia Research, Zoetermeer, Netherlands) and had similar compositions, including similar fatty acid profiles, except for the addition of LCPs. The PL-LCPs formula used is currently on the market (Aptamil with Milupan; Milupa, Friedrichsdorf, Germany).
Balance studies
Intakes of formulas or PBM were determined by weighing bottles or, in the case of tube feeding, by recording the volume in syringes. Balance studies with separate collections of urine (24 h ) and feces (72 h) were begun when infants were 28-d old. Fecal collections were carried out by bracketing with carmine red. Fifty milligrams of carmine red was dissolved in 3 mL distilled water and given either through a nasogastric tube or orally just before the 1200 feeding. Feces were then collected, including the first red stool and excluding the "second" first red stool about 3 d later. Collection was done by using plastic sheets placed inside diapers. Corrections were made for accidental losses of feces in diapers (double weighing of the diaper) and for feces sticking to the buttocks of the infants (double weighing of the cleaning swabs).
The total amount of feces collected during the 3-d balance period was weighed and homogenized and a small sample of the homogenate was freeze-dried. Fat excretion was determined by using a modification of the method of Jeejeebhoy et al (26) , with twice as much hydrochloric acid added. Excretion amounts were calculated by multiplying the volume of feces produced by the concentration of the compound of interest. Intestinal absorption was calculated by dividing the apparent amount absorbed (intake minus excretion) by the intake and multiplying by 100.
Determination of fatty acids in formulas and feces
Contents of individual fatty acids in the feedings and feces were determined by high-resolution capillary-gas chromatography. Analyses were done in triplicate. Fresh fecal samples (5-10 mg each) were subjected to trans-esterification by hydrochloric acid methanol after the addition of nonanoic and heptadecanoic acids as internal standards. Fatty acid methyl esters were separated and identified with a gas chromatograph (5890 II; Hewlett Packard, Amstelveen, Netherlands) equipped with a fused silica column (Supelcowax 10; 60 m ϫ 0.20 mm internal diameter; 0.20-m film thickness; Supelco, Zwijndrecht, Netherlands), a flame ionization detector (280 ºC), and a split-splitless injector used in splitless mode (280 ºC).
The gas chromatograph was operated with the following temperature program: 60 ºC initially for 5 min, raising of the oven temperature by 20 ºC/min until 205 ºC was reached, and holding at this temperature for 15 min. The temperature was then increased by 0.20 ºC/min until 222 ºC was reached. Helium was used as a carrier gas (2 mL/min) and peak areas were calculated with HPChem station software (Hewlett Packard) by using nonanoic and For the purposes of this study, fecal hydroxy fatty acids were assumed to be represented by the gas-chromatographic peaks that changed retention time after acetylation of fatty acid methyl esters. Acetylation of hydroxy fatty acid methyl esters was done in selected fecal samples with acetyl chloride for 1 h at 100 ºC (Merck, Milan, Italy). Under the gas-chromatographic conditions used, no coelution occurred between fecal hydroxy fatty acids and any of the LCPs. Selected fatty acids were identified with use of a quadrupole mass spectrometer (MD 800 GC-MS; Fisons, Milan, Italy). No attempt was made to identify trans fatty acids.
Statistical analysis
Data are presented as group means ± SEMs unless otherwise stated. Group comparisons were done with analysis of variance; differences among groups were tested with Tukey posttests. All calculations were done with the SYSTAT statistical package (version 5.2; Systat Inc, Evanston, IL).
RESULTS
Clinical characteristics of the infants studied were not different between groups (Table 2 ). Dietary intakes of PBM or formula, fecal output, and fat-balance data are given in Table 3 . Infants fed PBM had a higher fluid intake, which is often recommended with breast milk, which has a lower energy and protein content than preterm formulas. Fluid intake was also higher in infants fed PLLCPs formula than in those fed the other two formulas. This made fat intakes comparable among the study groups.
The infants fed PBM had the lowest fecal fat content (226.0 ± 69.9 mg/g); the amount was not significantly different from that in the PL-LCPs group (226.4 ± 62.7 mg/g). Infants in the other two formula groups had significantly higher values (305.3 ± 92.6 and 273.7 ± 59.9 mg/g, respectively, in the NLCPs and TG-LCPs groups; P = 0.002). These differences were also found for percentages of total fat absorption because fecal output was not different among the four groups.
Intakes and output of individual fatty acids are given in Tables  4 and 5 . Palmitic acid intake in the PBM and PL-LCPs groups was not different but the intake values were significantly higher that those in the NLCPs and TG-LCPs groups. In the PBM group, AA intake was 32.0 ± 2.1 mg · kg Ϫ1 · d Ϫ1 but intake of total nϪ6 LCPs was three times higher (92.9 ± 5.6 mg · kg Ϫ1 · d Ϫ1 ). The same difference applied to intakes of DHA and total nϪ3 LCPs, which were 18.0 ± 1.3 and 37.7 ± 2.9 mg · kg Ϫ1 · d Ϫ1 , respectively, indicating the presence of other nϪ3 and nϪ6 polyunsaturated fatty acids in addition to AA and DHA. Lower amounts of these other fatty acids were found in the PL-LCPs formula but there were virtually none in the TG-LCPs formula.
Metabolizable intakes of individual fatty acids in the 77 infants are shown in Table 6 . Intestinal absorption of each individual fatty acid for which dietary intake could be calculated is shown in Table  7 . Palmitic acid was better absorbed from PBM than from formulas. Linoleic acid was also better absorbed from PBM (88.1 ± 3.0%) and PL-LCPs formula (91.3 ± 1.7%) than from the NLCPs (69.7 ± 3.4%) and TG-LCPs (68.9 ± 4.0%) formulas. AA was absorbed in similar percentages from PBM, PL-LCPs, and TG-LCPs. Percentages of DHA absorption were similar in the PBM and TG-LCPs groups but lower than that in the PL-LCPs group.
DISCUSSION
This study showed that in small preterm infants fed PBM, LCPs are not absorbed completely, as has been believed, and that LCPs bound to phospholipids are better absorbed than triacylglycerol LCPs from either formula or breast milk. The study provided further evidence that intestinal absorption of total fat and palmitic acid is better from breast milk than from formula.
Reliable calculation of intestinal absorption of individual polyunsaturated fatty acids requires processing of feces immediately after excretion to avoid bacterial and oxidative degradation of the most unsaturated fatty acids. Use of high-resolution capillary-gas chromatography is also necessary to minimize coelution of several unknown peaks (mostly hydroxy fatty acids) that may interfere with determination of the more common dietary fatty acids. We paid attention to these conditions and found that Ϸ80% of AA and DHA from breast milk was absorbed. In PBMfed infants, this value approximated the amount of total fat absorption and was similar to the palmitic acid absorption (78.4 ± 4.0%) but lower than that of oleic acid absorption (85.8 ± 3.2%). Absorption of LCPs from breast milk was thus not better than absorption of saturated fat.
In breast milk, palmitic acid is preferentially esterified to the center sn-2 position and LCPs are more represented at the sn-2 and sn-3 positions (14, 15, 27) . It is thus conceivable that LCPs at the external position may have a disadvantage compared with fatty acids attached to the center position, which does not have to be cleaved for absorption. Lingual, gastric, and pancreatic lipases preferentially hydrolyze the sn-1 and sn-3 ester bonds of triacylglycerols but their activity is greater toward short-and medium-chain fatty acids than toward long-chain fatty acids, especially LCPs (16, 28, 29) .
Intestinal absorption of AA and DHA from TG-LCPs formula was similar to that from PBM. This is an important finding because this formula contained highly unsaturated triacylglycerol molecular species, with up to 40% DHA and up to 30% AA. Unlike in breast milk triacylglycerols, in which DHA has a clear positional specificity (14) , DHA in algal oils does not have a strong positional specificity; there are similar proportions at the sn-1, sn-2, and sn-3 positions (data not shown). On the basis of work by Bottino et al (16) , who described resistance of certain LCPs of fish oils to hydrolysis by pancreatic lipase, and data of Hernell et al (17) , relatively low absorption might also have been expected with the highly unsaturated triacylglycerols from algae. However, our data indicated that LCPs from these triacylglycerols were absorbed as efficiently as those from breast milk, even without the lipolytic enzymes that are present in breast milk but not in formulas (17) . Differences in the molecular structure of these algal triacylglycerols and fish oils (with which most studies have been performed) could be responsible for the different digestibility and absorption of these two products. DHA from PL-LCPs was absorbed better than DHA from PBM. This finding clearly indicates that intestinal absorption of phospholipids in preterm infants is efficient. Data on intestinal absorption of phospholipids in human infants and adults is lacking and information on this issue is derived mainly from studies in animals (30) . It is known, however, that under normal dietary conditions in human adults, dietary phospholipids are a minor portion of the phospholipids presented to the gut for intestinal absorption; the majority are phospholipids of biliary origin (31) . Whether this also applies in newborn infants is not known. However, to ensure intake of LCPs from a phospholipid source in the range of intake of breast milk, dietary intake of phospholipids must far exceed the phospholipid content of breast milk (18) .
Proportions of intestinal absorption representing the sum of nϪ6 and nϪ3 LCPs were similar to those of AA and DHA, DHA intakes were > 85% of total nϪ6 and nϪ3 LCPs, respectively, and eicosapentaenoic acid was absent. Mean intake of total nϪ3 LCPs was lower in the PL-LCPs group than in the PBM and TG-LCPs groups (25.9, 37.7, and 37.9 mg · kg Ϫ1 · d Ϫ1 , respectively, in the three groups).
Intakes of LCPs in PBM-fed preterm infants were slightly higher than those reported by Boehm et al (32) , who compared a group fed breast milk with groups fed an unsupplemented formula and a supplemented formula similar to the PL-LCPs formula in our study. This difference in intake of LCPs in our study and that in the study by Boehm et al may have resulted from different fluid intakes or from the fact that the infants in our study were fed a PL-LCPs formula with a higher energy concentration than the infants in the study by Boehm et al (332.8 compared with 292.9 kJ/d).
Fecal output data indicated that losses of LCPs in preterm infants are not negligible. Infants fed NLCPs formula lost Ϸ4.6 ± 1.2 mg nϪ6 LCPs · kg Ϫ1 · d Ϫ1 and 4.2 ± 1.9 mg nϪ3 LCPs · kg
A portion of these fecal LCPs may derive from endogenous sources--bile lipids, enterocytes shed into the gut lumen, and even bacterial walls. It was shown that bile in human adults contains LCPs (33), but no information is available on children or premature infants nor do data exist on the amount of bile produced. It is likely, however, that a large portion of the LCPs of bile lipids is absorbed along the intestinal tract. Although it is theoretically possible that LCPs in feces are not a reflection of gut absorption, circumstantial evidence suggests that this is not the case. First, much higher amounts are found in stools of infants consuming LCPs in their diets. Second, when LCP content of PBM rises, so does the amount excreted in the stool.
We also calculated metabolizable intakes (Table 6 ) because we believe that these values provide better estimates of the amounts of LCPs entering the body than do values derived from diet alone. Furthermore, we believe that fatty acid content, especially LCP content, in infant formulas is better specified in absolute amounts than as a percentage of total fat because fat content of infant formulas may differ markedly. A difference in total fat of 1.2 g/d (for example, an increase from 3.2 to 4.4 g/d) could lead to a difference in estimated LCP intake of 28%. It is also worth emphasizing that in our subjects Ϸ20-25% of dietary LCPs were lost in the feces.
In conclusion, our study showed that there are substantial amounts of LCPs in the feces of PBM-and formula-fed preterm infants. We also found that DHA from egg phospholipids was absorbed better than DHA from PBM. DHA and AA from singlecell oils were absorbed as efficiently as DHA and AA from breast milk fat.
